Therapeutic Category
- Antineoplastic Agent, Anthracycline
- Antineoplastic Agent, Topoisomerase II Inhibitor
Medication Safety Issues
Sound-alike/look-alike issues:
IDArubicin may be confused with DAUNOrubicin, daunorubicin/cytarabine, DOXOrubicin, epiRUBicin, idaruCIZUmab, idelalisib, valrubicin
Idamycin PFS may be confused with Adriamycin
High alert medication:
The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes (chemotherapeutic agent, parenteral and oral) which have a heightened risk of causing significant patient harm when used in error (High-Alert Medications in Acute Care, Community/Ambulatory Care, and Long-Term Care Settings).
